MAPK3 and viral infectious disease: NPTr cells pre-treated with inhibitors of ERK1/2 (U0126), p38 (SB 202190) and JAK/STAT (JAK Inhibitor I) in the absence of a virus infection showed basal levels of phosphorylation similar to those observed in control groups.